Pharmaceutical Testing and Analytical Services Market: Introduction
According to the report, the global pharmaceutical testing and analytical services market was valued at US$ 3.5 Bn in 2019. It is projected to expand at a CAGR of ~11% from 2020 to 2030. Pharmaceutical testing and quality assurance are important stages in the pharmaceutical industry. Testing and analysis are carried out as people’s lives depend on the quality and quantity measure of a given medicine. Bioanalytical testing, method development & validation, raw material testing, stability testing, and microbial testing are commonly employed tests adopted in pharmaceutical and medical devices industries. The expansion of the global pharmaceutical testing and analytical services market can be ascribed to rise in the number of clinical trials and increase in R&D spending.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55191
North America dominated the global pharmaceutical testing and analytical services market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry and increase in incidence of disease are likely to boost the market in North America. Furthermore, the presence of major market players who are focused on design and development of new treatment options for the treatment of major chronic diseases is likely to further drive the market in North America. Asia Pacific is likely to be a highly lucrative region of the global pharmaceutical testing and analytical services market. It is projected to expand at a rapid pace during the forecast period.
Rise in Number of Clinical Trials and Increase in R&D Spending to Drive Global Market
The increase in the number of clinical trials is projected to boost the pharmaceutical testing and analytical services market. Rising prevalence of cancer is a key factor driving the number of clinical trials being conducted. Furthermore, it is estimated that the number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. Increase in R&D spending and focus of biopharmaceutical companies on boosting revenues has propelled the pharmaceutical testing and analytical services market.
Request COVID Analysis on Pharmaceutical Testing and Analytical Services Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55191
Inorganic growth is a key strategy adopted by major players operating in the pharmaceutical testing and analytical services market in order to consolidate their position in the market. On January 3, 2020, Charles River Laboratories International, Inc. acquired HemaCare, a leading company specializing in the production of human derived cellular products for the cell therapy market. These factors are estimated to propel the pharmaceutical testing and analytical services market during the forecast period.
Bioanalytical Testing Segment to Dominate Global Market
Based on service type, the global pharmaceutical testing and analytical services market has been divided into bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The bioanalytical testing segment has been further segmented into cell-based assays, virology testing, and others. The method development & validation segment has been sub-segmented into extractables & leachables method development and validation, stability-indicating method validation, process impurity method development & validation, and others. The raw material testing segment has been split into heavy metal testing, complete compendial testing, and others. The stability testing segment has been further classified into drug substance stability testing, formulation evaluation stability testing, and others. The microbial testing segment has been further divided into microbial limit testing, sterility testing, endotoxin testing, and others. The bioanalytical testing segment dominated the global pharmaceutical testing and analytical services market in 2019. This trend is projected to continue during the forecast period.
The increase in use of cell-based assay, virology, and other tests in drug development is likely boost the bioanalytical testing segment during the forecast period. Cell-based assays have been a key component in streamlining the drug development process, helping drugs to be introduced in the market in a rapid and efficient manner.
The method development & validation segment was followed by the bioanalytical testing segment, in terms of market share, in 2019.
Pharmaceutical & Biopharmaceutical Companies to Offer Lucrative Opportunities
In terms of end user, the global pharmaceutical testing and analytical services market has been split into medical device companies, pharmaceutical & biopharmaceutical companies, and others. The pharmaceutical & biopharmaceutical companies segment accounted for a prominent share of the global pharmaceutical testing and analytical services market in 2019. The expansion of the segment can be attributed to a surge in focus of biopharmaceutical companies on expansion, shifting fixed costs to variable costs, and incorporation of technological advances in their research process, which is highly cost intensive. These factors are fueling the outsourcing of the research & development process, thereby boosting the segment.
Request Customization on Pharmaceutical Testing and Analytical Services Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=55191
North America to Dominate Global Pharmaceutical Testing and Analytical Services Market
The global pharmaceutical testing and analytical services market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pharmaceutical testing and analytical services market in 2019. It was followed by Europe. The U.S. dominated the market in North America, owing to the presence of major market players, significant healthcare expenditure, and increase in research activities across the region. Robust expansion of the market in the region can be attributed to increase in the number of clinical trials and a rise in the demand for biosimilars owing to patent expiry, which fuels the demand for rapid conduction of trials and regulatory approvals. This, in turn, fuels the demand for analytical testing from pharmaceutical manufacturers and consequently boosts the market.
The pharmaceutical testing and analytical services market in Asia Pacific is anticipated to expand at a rapid rate from 2020 to 2030.
Competition Landscape of Pharmaceutical Testing and Analytical Services Market
The global pharmaceutical testing and analytical services market is fragmented in terms of number of players. Key players operating in the global market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc, RD Laboratories, Inc., WuXi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma.
Global Pharmaceutical Testing and Analytical Services Market: Segmentation
- Pharmaceutical Testing and Analytical Services Market, by Service Type
- Bioanalytical Testing
- Cell-based Assays
- Virology Testing
- Others
- Method Development & Validation
- Extractables & Leachables Method Development and Validation
- Stability-indicating Method Validation
- Process Impurity Method Development & Validation
- Others
- Raw Material Testing
- Heavy Metal Testing
- Complete Compendial Testing
- Others
- Stability Testing
- Drug Substance Stability Testing
- Formulation Evaluation Stability Testing
- Others
- Microbial Testing
- Microbial Limit Testing
- Sterility Testing
- Endotoxin Testing
- Others
- Others
- Pharmaceutical Testing and Analytical Services Market, by End User
- Medical Device Companies
- Pharmaceutical & Biopharmaceutical Companies
- Others
- Pharmaceutical Testing and Analytical Services Market, by Region
- North America
- S.
- Canada
- Europe
- Germany
- K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Trending Reports of Transparency Market Research –
Minimally Invasive Surgery Market –
Nurse Call Systems Market –
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
